Cue Biopharma

Cambridge, United States

Cue Biopharma is a developer of a productive platform for the treatment of cancer and autoimmune disease.

$30.0M raised

Apr 2026

Post-IPO Equity

Biopharma Biotechnology Health Care Medical Device

Top Investors

MDB Capital Group

Founder Contacts

30,000+ verified contacts

Get Instant Access

Emails, phones & LinkedIn profiles

Frequently Asked Questions about Cue Biopharma

How much funding has Cue Biopharma raised?

Cue Biopharma has raised $30.0M in total funding. The most recent round was Post-IPO Equity. The last funding was announced in April 2026.

Who are Cue Biopharma's investors?

Cue Biopharma's investors include MDB Capital Group.

Where is Cue Biopharma headquartered?

Cue Biopharma is headquartered in Cambridge, United States.

What does Cue Biopharma do?

Cue Biopharma is a developer of a productive platform for the treatment of cancer and autoimmune disease.

What stage is Cue Biopharma at?

Cue Biopharma is at the Post-IPO Equity stage.

Cite this page

Free to use in articles, research, and reference works. Stable URL — will not change. Data on this page last updated April 30, 2026.

MLA

"Cue Biopharma — Funding & Investors." VCBacked, April 30, 2026, https://www.vcbacked.co/company/cue-biopharma. Accessed July 3, 2026.

APA

VCBacked. (2026). Cue Biopharma — Funding & Investors. Retrieved July 3, 2026, from https://www.vcbacked.co/company/cue-biopharma

Wikipedia (cite web)

{{cite web |title=Cue Biopharma — Funding & Investors |url=https://www.vcbacked.co/company/cue-biopharma |website=VCBacked |access-date=July 3, 2026}}

Profile data sourced and verified per the VCBacked methodology. Last funding round dated April 30, 2026.

Similar Companies in Biopharma

View all

Allterum Therapeutics

Living In Silico Inc.